NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
25/02/2022
Voltar para busca
Dado oficial do USPTO
VACCICHECK
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
VACCICHECK
ST13
US500000085352842Classe
1, 5, 9, 10
Pedido
85352842
Registro
4134419
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
32
Atualização mais recente
25/02/2022
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 9, 10
Data de depósito
22/06/2011
Data de registro
01/05/2012
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
25/02/2022
Última transação
25/02/2022
Escritório responsável
United States Patent and Trademark Office
Código da situação
800
Cadastro oficial
Principal Register
Primeiro uso
31/12/2006
Primeiro uso no comércio
24/08/2010
Código do desenho
4
Tipo de titular
13
Localização do titular
Kibbutz Galed, IL
Examinador
MULLEN, MARK
Unidade examinadora
M20
Localização atual
TMO LAW OFFICE 111
Titulares e representantes
Titulares
B. L. (pessoa física)
Representantes
Jonathan Agmon Soroker Agmon Nordman
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 9Classe 10
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Active chemical ingredients for use in the manufacture of veterinary pharmaceuticals for diagnosing antibodies in animals; diagnostic kits consisting primarily of monoclonal antibodiesbuffersreagents to monitor antibodies; catalysts for chemical and biochemical processes; chemical preparations for scientific purposes; chemical test kits for diagnosing antibodies for laboratory or research use; chemical preparations for use in the manufacture of veterinary preparations; chemicals for use in the biochemical and chemical industry; laboratory chemicalsan antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use; reagent for chemical analyses; reagents for use in scientific apparatus for chemical or biological analysis; diagnostic preparations for clinical or medical laboratory use; immunohistochemistry detection kits consisting of domestic animals' reagents and antibodies for use in inspection in the veterinary diagnostics industry; excipients for use in the manufacture of veterinary preparations; all of the foregoing excluding goods for use in blood glucose monitoring or diabetes care for humans
Classe 5
Chemical reagents for medical or veterinary purposes; diagnostic agentspreparations and substances for veterinary purposes; diagnostic kits consisting primarily of monoclonal antibodiesbuffersreagents for use in disease testing; diagnostic preparations for medical or veterinary use; In-vitro diagnostic kits for the detection and monitoring of antibodies for medical or veterinary use; medical diagnostic reagents for the analysis of body fluids; all of the foregoing excluding goods for use in blood glucose monitoring or diabetes care for humans
Classe 9
Laboratory chemical reactors; diagnostic apparatus for the detection of pathogens for laboratory or research use; testing sample collection equipmentwipes and swabs for use in clinical and industrial diagnostic testing; all of the foregoing excluding goods for use in blood glucose monitoring or diabetes care for humans
Classe 10
Diagnostic apparatus for the detection of antibodies to various pathogensantibodies to infectious Canine HepatitisCanine Parvovirus and Distemper Virus or Feline PanleukopeniaHerpes Virus and Calici Virusfor veterinary use; diagnostic kits consisting primarily of probesbuffers and reagents for use in microbial and antibody testing; medical diagnostic instruments for the analysis of body fluids; Medical bags adapted for and sold with medicalsurgical and veterinary instruments; veterinary apparatustools for evaluating the antibody response to the core vaccination or infection by Infectious Canine HepatitisCanine Parvovirus and Distemper VirusFeline PanleukopeniaHerpes Virus and Calici Virus; all of the foregoing excluding goods for use in blood glucose monitoring or diabetes care for humans
Publicações
Histórico de despachos e eventos da marca no USPTO.
32 publicações encontradas
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
25/02/2022
9G8P
REGISTERED - SEC. 9 GRANTED/CHECK RECORD FOR SEC. 8
25/02/2022
8PRT
REGISTERED - PARTIAL SEC. 8 (10-YR) ACCEPTED
25/02/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
25/02/2022
E89R
TEAS SECTION 8 & 9 RECEIVED
29/09/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
18/08/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
18/08/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
18/08/2021
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
01/05/2021
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
24/10/2017
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
24/10/2017
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
24/10/2017
ES8R
TEAS SECTION 8 RECEIVED
24/09/2017
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
01/05/2017
R.PR
REGISTERED-PRINCIPAL REGISTER
01/05/2012
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
14/02/2012
PUBO
PUBLISHED FOR OPPOSITION
14/02/2012
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
25/01/2012
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
11/01/2012
ALIE
ASSIGNED TO LIE
06/01/2012
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
16/12/2011
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/12/2011
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/12/2011
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/12/2011
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/10/2011
GNRT
NON-FINAL ACTION E-MAILED
06/10/2011
CNRT
NON-FINAL ACTION WRITTEN
06/10/2011
DOCK
ASSIGNED TO EXAMINER
04/10/2011
MPMK
NOTICE OF PSEUDO MARK MAILED
29/06/2011
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
28/06/2011
NWAP
NEW APPLICATION ENTERED
25/06/2011
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace VACCICHECK ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.